🏃 Grab this Black Friday offer early. Get up to 55% off InvestingPro now!CLAIM SALE

Aphria Tumbles After Lockdowns Hurt Sales, Pinch Margins

Published 2021/04/12, 15:57
Updated 2021/04/12, 15:58
©  Reuters
APHA
-
TLRY
-

By Dhirendra Tripathi

Investing.com – Aphria (TSX:APHA) shares fell more than 13% after disappointing earnings outweighed any euphoria generated by its decision to combine with Tilray (NASDAQ:TLRY) to create the world's largest global cannabis company.

Compared with the same quarter a year ago, lockdowns took a toll on its revenue, margins and bottom line.

Net revenue for the three months ended February 28 was C$153.6 million ($122.5 million), an increase of 6.4% from C$144.4 million in the same period last year. But that fell short of the expected C$162.4 million. The company suffered what it called a “transitory reduction in demand during the quarter.”  

Its adjusted cannabis gross margin fell to 39.2% from 42.7% from the February quarter a year ago. The company reported a net loss of C$360,996, or C$1.14, against expectations for a loss of around 4 cents.

The average retail selling price of medical cannabis, before excise tax, decreased to C$6.69 per gram in the quarter, compared to C$6.96 per gram in the prior quarter.

The company said the decline was a result of specific pricing programs offered to assist patients in need who have been negatively affected by the pandemic, along with other promotional programs.

The company’s proposed merger with Tilray will be put to vote on April 16.

 

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.